HGEN-005

N/A

Report date: 2024/11/13 13:48:46

Base Information

Drug NameHGEN-005
Drug Alias NameHGEN-005KB-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsAnti-Adhesion G protein-coupled receptor E1
TargetsAdhesion G protein-coupled receptor E1
Therapy Area/IndicationsEosinophilic Granulomatosis With PolyangiitisAsthmaEosinophilic Esophagitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHumanigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaran Therapeutics IncHumanigen Inc
Inactive CompaniesN/A
Active IndicationsEosinophilic Granulomatosis With PolyangiitisAsthmaEosinophilic Esophagitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A